HR 2666: MEDICAID VBPS FOR PATIENTS (MVP) ACT; ALL PROVISIONS OF THE BILL HR 5539: OPTIMIZING RESEARCH PROGRESS HOPE AND NEW CARES ACT (ORPHAN CURES ACT); ALL PROVISIONS OF THE BILL HR 6094: PROVIDING REALISTIC OPPORTUNITY TO EQUAL AND COMPARABLE TREATMENT FOR RARE ACT (PROTECT RARE ACT); ALL PROVISIONS OF THE BILL S 3131: OPTIMIZING RESEARCH PROGRESS HOPE AND NEW CARES ACT (ORPHAN CURES ACT); ALL PROVISIONS OF THE BILL GENERAL DISCUSSIONS REGARDING MEDICAID ACCESS TO RARE DISEASE THERAPIES HR 2369: VALID ACT OF 2023; ALL PROVISIONS OF THE BILL HR 2666: MEDICAID VBPS FOR PATIENTS ACT (MVP ACT); PROVISIONS RELATED TO OUTCOME BASED ARRANGEMENTS (OBA) AND VALUE BASED ARRANGEMENTS (VBA) HR 4408: PROMISING PATHWAY ACT; ALL PROVISIONS OF THE BILL S 1906: PROMISING PATHWAY ACT; ALL PROVISIONS OF THE BILL GENERAL DISCUSSIONS REGARDING 340B DRUG PRICING PROGRAM REFORM, RARE DISEASE GENE THERAPY ACCESS, CENTERS FOR MEDICARE & MEDICAID SERVICES (CMS) PROPOSED PRICE JUSTIFICATION SURVEY, HEMOPHILIA GENE THERAPY, RARE DISEASE DRUG DEVELOPMENT
MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 5 - Government Accountability Office (GAO) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BIOMARIN PHARMACEUTICAL INC.
770 Lindaro Street, San Rafael, CA, 94901, US
JOHN EDWARD GREISSING JOHN EDWARD GREISSING KATHRYN LOWELL